You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12

Authors

  • Itai Gueta The Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel PubMed articlesGoogle scholar articles
  • Hillel Halkin The Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Noa Markovits The Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Ronen Loebstein The Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Itai Gueta, Sheba Medical Center, Tel Hashomer, Ramat Gan, 5262000, Israel; itai.gueta{at}sheba.health.gov.il
View Full Text

Citation

Gueta I, Halkin H, Markovits N, et al
Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12
Gut 2018;67:1904.

Publication history

  • Received November 16, 2017
  • Revised November 21, 2017
  • Accepted November 23, 2017
  • First published November 28, 2017.
Online issue publication 
December 05, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.